Skip to main content
Have a personal or library account? Click to login
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model Cover

Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model

Open Access
|Jun 2026

Figures & Tables

Figure 1.

The creation of endometriosis model. The stages of endometriosis model formation (right to left).

Figure 2.

Flow-chart of the study. bLF, bovine lactoferrin; CMC, carboxymethylcellulose; P, progesterone.

Figure 3.

The post-treatment immunohistochemical staninig of endometriotic lesions. Arrow represents each group’s TNF-α, IL-1β, PGR receptors. bLF, bovine lactoferrin; IL, interleukin; PGR, progesterone receptor; TNF-α, tumor necrosis factor-alpha.

Figure 4.

Post-treatment TNF-α, IL-1β, PGR receptor distrbution of endometriotic lesions. bLF, bovine lactoferrine; IL, interleukin; PGR, progesterone receptor; TNF-α, tumor necrosis factor-alpha.

The pre-treatment endometriotic lesion measurements

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
Total volume (mm3)0.02319 ± 0.028370.0643 ± 0.145570.01694 ± 0.013870.03822 ± 0.030760.358
Total ellipsoid volume (mm3)0.01181 ± 0.01490.03078 ± 0.075770.00802 ± 0.006880.019 ± 0.014470.112
Total adhesion score1.875 ± 1.35621.33333 ± 1.224741 ± 11.55556 ± 1.013790.480

The post-treatment PGR, TNF-α, and IL-1β expression in endometriotic tissue

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
TNF-α3 ± 01.67 ± 0.522 ± 01 ± 00.001**
IL-1β2.83 ± 0.412 ± 02.17 ± 0.411.17 ± 0.410.001**
PGR2.83 ± 0.412.17 ± 0.412.17 ± 0.411 ± 00.001**

The differences of pre- and post-treatment measurements

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
Total volume (mm3)−0.01 ± 0.04−0.05 ± 0.14−0.01 ± 0.02−0.03 ± 0.030.653
Total ellipsoid volume (mm3)−0.01 ± 0.02−0.02 ± 0.08−0.01 ± 0.01−0.01 ± 0.020.413
Total adhesion score−0.13 ± 2.640.56 ± 2.010.78 ± 1.480.56 ± 1.010.890

The post-treatment TAS and TOS values

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
TAS (mmol trolox equiv./kg wet weight)30.73 ± 16.0723.14 ± 7.6322.75 ± 9.6621.5 ± 2.110.623
TOS (µmol H2O2 equiv./gprot)81.45 ± 16.6776.12 ± 17.982.39 ± 27.1285.54 ± 11.690.318

The post treatment blood progesterone and LF values

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
Progesterone (ng/mL)2.84 ± 1.943.83 ± 3.292.98 ± 1.823.19 ± 1.280.0627
LF (µ/mL)35.54 ± 3.8337.01 ± 5.827.84 ± 1.4238.56 ± 5.750.001**

The post-treatment endometriotic lesion measurements

Control (n = 10) (mean ± sd)bLF (n = 10) (mean ± sd)Progesteron (n = 10) (mean ± sd)Mixed (n = 10) (mean ± sd)P
Total volume (mm3)0.01 ± 0.030.02 ± 0.010 ± 00.01 ± 0.010.225
Total ellipsoid volume (mm3)0.01 ± 0.010.01 ± 0.010 ± 00.01 ± 0.010.265
Total adhesion score1.75 ± 1.391.89 ± 1.051.78 ± 1.22.11 ± 0.930.959
DOI: https://doi.org/10.2478/abm-2026-0019 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 161 - 169
Published on: Jun 30, 2026
In partnership with: Paradigm Publishing Services

© 2026 İrem Şenyuva, Duygu Baki Acar, Hasan Hüseyin Demirel Bayat, Funda Karabağ, Ece Tunç, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.